These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9708645)

  • 1. Phase II study of ifosfamide and mesna in patients with metastatic breast cancer.
    Walters RS; Holmes FA; Valero V; Esparza-Guerra L; Hortobagyi GN
    Am J Clin Oncol; 1998 Aug; 21(4):413-5. PubMed ID: 9708645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.
    Ingle JN; Krook JE; Mailliard JA; Hartmann LC; Wieand HS
    Am J Clin Oncol; 1995 Dec; 18(6):498-501. PubMed ID: 8526193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group.
    Sutton G; Blessing JA; Park R; DiSaia PJ; Rosenshein N
    Obstet Gynecol; 1996 May; 87(5 Pt 1):747-50. PubMed ID: 8677079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.
    Kiraz S; Baltali E; Güler N; Barista I; Benekli M; Celik I; Güllü IH; Kars A; Tekuzman G; Firat D
    J Chemother; 1996 Aug; 8(4):310-4. PubMed ID: 8873839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide bolus followed by five days continuous infusion in extensively pretreated patients with advanced breast cancer: a phase II study.
    Bisagni G; Boni C; Manenti AL; Moretti G; Rondini E; Sassi M; Zadro A; Savoldi L
    Tumori; 1998; 84(6):659-61. PubMed ID: 10080671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH
    Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer.
    Pronzato P; Vigani A; Pensa F; Vanoli M; Tani F; Vaira F
    Am J Clin Oncol; 1997 Oct; 20(5):519-21. PubMed ID: 9345341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
    Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Dunnington JS; Hong WK
    Am J Clin Oncol; 1996 Aug; 19(4):379-82. PubMed ID: 8677909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.
    Ajani JA; Abbruzzese JL; Goudeau P; Faintuch JS; Yeomans AC; Boman BM; Nicaise C; Levin B
    J Clin Oncol; 1988 Nov; 6(11):1703-7. PubMed ID: 3141592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B study 8552.
    Case DC; Anderson J; Ervin TJ; Gottlieb A
    Hematol Oncol; 1991; 9(4-5):189-96. PubMed ID: 1743622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; McGuire WP; Patton T; Look KY
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.
    Williamson SK; Wolf MK; Eisenberger MA; O'Rourke MA; Brannon W; Crawford ED
    Am J Clin Oncol; 1996 Aug; 19(4):368-70. PubMed ID: 8677906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
    Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide.
    Goren MP; Anthony LB; Hande KR; Johnson DH; Brade WP; Frazier MW; Bush DA; Li JT
    J Clin Oncol; 1998 Feb; 16(2):616-21. PubMed ID: 9469350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barrett RJ; McGehee R
    Am J Obstet Gynecol; 1992 Feb; 166(2):556-9. PubMed ID: 1536229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC; Solidoro A; Casanova L; Vallejos C; Rodriguez W
    J Exp Ther Oncol; 1996 Mar; 1(2):84-7. PubMed ID: 9414391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule.
    Serrone L; Zeuli M; Gamucci T; Nardi M; Cognetti F
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):206-10. PubMed ID: 11320663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 8552.
    Case DC; Anderson J; Ervin TJ; Gottlieb A
    Med Pediatr Oncol; 1988; 16(3):182-6. PubMed ID: 3132591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinoma.
    Turrill M; Spicer DV; Kelley AS; Herman RL; Russell CA; Muggia FM
    Cancer Invest; 1995; 13(2):160-4. PubMed ID: 7874569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.